Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

  • Price (USD)0.89
  • Today's Change0.006 / 0.68%
  • Shares traded21.63k
  • 1 Year change5.70%
  • Beta0.2933
Data delayed at least 20 minutes, as of Nov 22 2024 10:19 GMT.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+22.30%
NAVBioPharma Credit PLC (Ordinary Share)+21.43%
Morningstar's BenchmarkNo benchmark--

Key statistics

As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.89, -5.72% below its 52-week high of 0.944, set on Jan 30, 2024.
52-week range
Today
0.8267Dec 07 20230.944Jan 30 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.19bn
Market cap1.04bn USD
Total assets1.17bn USD
Total expense ratio1.15%
High0.89
Low0.88
Previous close0.884
Average volume598.25k
YTD Change+5.95%
Beta0.2933
Diluted NAV (est)0.9829
Diluted NAV (last pub)0.9723
Premium/Discount-10.07%
Net Gearing0.00%
Annual div (ADY)0.070 USD
Annual div yield (ADY)7.92%
Div ex-dateSep 26 2024
Div pay-dateOct 29 2024
Data delayed at least 20 minutes, as of Nov 22 2024 10:19 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.